Applications of single-cell omics for chimeric antigen receptor T cell therapy

Area of Science:

• Immunology and Cancer Therapy
• Genomics and Molecular Biology

Background:

• Chimeric antigen receptor (CAR) T cell therapy represents a significant advancement in cancer treatment.
• Traditional bulk analyses provide averaged data, masking the heterogeneity crucial for understanding treatment efficacy.
• Single-cell analysis offers a powerful tool to dissect the complexities of the tumor microenvironment in immunotherapy.

Purpose of the Study:

• To provide a comprehensive review of recent preclinical and clinical findings in CAR T cell therapy.
• To highlight the critical role of single-cell analysis in advancing CAR T cell therapy research.
• To categorize and summarize studies where single-cell analysis provided key insights.

Main Methods:

• Review of recent scientific literature focusing on CAR T cell therapy.
• Categorization and summarization of studies utilizing single-cell analysis.
• Analysis of insights gained from genomics, epigenomics, transcriptomics, proteomics, and multi-omics approaches.

Main Results:

• Single-cell analysis provides high-resolution data crucial for understanding CAR T cell therapy.
• Insights span genomics, epigenomics, transcriptomics, and proteomics, revealing treatment nuances.
• This detailed molecular understanding is vital for optimizing CAR T cell therapy in heterogeneous cancers.

Conclusions:

• Single-cell analysis is indispensable for deciphering the tumor microenvironment in CAR T cell therapy.
• The application of single-cell multi-omics is accelerating progress in adoptive cell therapy.
• Further research leveraging single-cell techniques will be key to maximizing the potential of CAR T cell therapy.